U.S. prevalence of endocrine therapy–naïve locally advanced or metastatic breast cancer

BACKGROUND: Variations in treatment choice, or late stage at first diagnosis, mean that, despite guideline recommendations, not all patients with hormone receptor (hr)–positive locally advanced or metastatic breast cancer (la/mbca) will have received endocrine therapy before disease progression. In...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Curr Oncol
Huvudupphovsmän: Nunes, A.P., Liang, C., Gradishar, W.J., Dalvi, T., Lewis, J., Jones, N., Green, E., Doherty, M., Seeger, J.D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Multimed Inc. 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6476436/
https://ncbi.nlm.nih.gov/pubmed/31043825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4163
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk